Phldb2 gene deletion results in a significant decrease in synaptic AMPA receptor density. Replicas were prepared from the CA1 region of the hippocampus and labelled for AMPA receptors ((A–C): GluA1–3; (D–F): GluA1) in combination with the NR1 subunit of NMDA receptors as a marker for excitatory synapses. The synaptic identity of these IMP cluster areas (purple area) was further confirmed by immunolabelling for the NR1 subunit visualized with 10 nm immunogold (black arrowheads in A and D). Immunoreactivity for GluA1–3 or GluA1 was visualized with 5-nm immunogold particles (orange arrowheads) in (A,D), respectively. (B,E) The numbers of immunoparticles for GluA1–3 (B) or GluA1 (E) in individual IMP clusters were plotted against the IMP cluster areas. In both cases, a statistically significant positive correlation between the AMPAR labelling numbers and synaptic areas was found regardless of genotype (Pearson’s correlation test for GluA1–3: the Phldb2+/+ mice, n = 43 synapses, r = 0.742, P < 0.001; the Phldb2−/− mice, n = 36 synapses, r = 0.896, P < 0.001, and Spearman’s rank-order test for GluA1: the Phldb2+/+ mice, n = 69 synapses, r = 0.344, P < 0.01; the Phldb2−/− mice, n = 69 synapses, r = 0.558, P < 0.001). However, significant reductions in synaptic GluA1–3 (C) and GluA1 (F) labelling densities were detected in the Phldb2−/− mice compared with the Phldb2+/+ mice (Mean ± SEM. Student’s t-test for GluA1–3, *P < 0.05, Spearman’s rank-order test for GluA1, *P < 0.05).